MED27 and thyroid cancer: The results showed CRSP8 re-expression restored the decreased cell growth and invasive ability to almost baseline levels in ATC cells (Supplementary Fig. S4B, C), suggesting CRSP8 indeed drives thyroid cancer cell survival.